19-1207091-T-TA
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000455.5(STK11):c.179dupA(p.Tyr60fs) variant causes a frameshift, stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 31)
Consequence
STK11
NM_000455.5 frameshift, stop_gained
NM_000455.5 frameshift, stop_gained
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.00
Genes affected
STK11 (HGNC:11389): (serine/threonine kinase 11) The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 19-1207091-T-TA is Pathogenic according to our data. Variant chr19-1207091-T-TA is described in ClinVar as [Likely_pathogenic]. Clinvar id is 234416.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK11 | NM_000455.5 | c.179dupA | p.Tyr60fs | frameshift_variant, stop_gained | 1/10 | ENST00000326873.12 | NP_000446.1 | |
STK11 | NM_001407255.1 | c.179dupA | p.Tyr60fs | frameshift_variant, stop_gained | 1/9 | NP_001394184.1 | ||
STK11 | NR_176325.1 | n.1315dupA | non_coding_transcript_exon_variant | 1/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK11 | ENST00000326873.12 | c.179dupA | p.Tyr60fs | frameshift_variant, stop_gained | 1/10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
STK11 | ENST00000652231.1 | c.179dupA | p.Tyr60fs | frameshift_variant, stop_gained | 1/9 | ENSP00000498804.1 | ||||
STK11 | ENST00000585748.3 | c.-82-11325dupA | intron_variant | 3 | ENSP00000477641.2 | |||||
STK11 | ENST00000593219.5 | n.179dupA | non_coding_transcript_exon_variant | 1/4 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Quest Diagnostics Nichols Institute San Juan Capistrano | Jan 07, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 26, 2018 | This duplication of one nucleotide is denoted STK11 c.179dupA at the cDNA level and p.Tyr60Ter (Y60X) at the protein level. The normal sequence, with the base that is duplicated in brackets, is TCTT[dupA]CGGC. The duplication creates a nonsense variant, which changes a Tyrosine to a premature stop codon. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. STK11 c.179dupA has been observed in individuals reported as having Peutz-Jeghers syndrome (Aretz 2005, Salloch 2010, Wang 2014). Additionally, the adjacent variants STK11 c.180C>G and c.180C>A, which also result in a premature stop codon at this residue (p.Tyr60Ter), have been reported in several individuals meeting clinical diagnostic criteria for Peutz-Jeghers syndrome (Wang 1999, Olschwang 2001, Lim 2003, Zhao 2012, Li 2017). We therefore consider STK11 c.179dupA to be pathogenic. - |
Peutz-Jeghers syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at